Pharmedic Pharmaceutical Medicinal JSC (HNX:PMC)

Vietnam flag Vietnam · Delayed Price · Currency is VND
129,900
+3,400 (2.69%)
At close: Apr 28, 2026
14.96%
Market Cap 1.21T
Revenue (ttm) 546.57B
Net Income (ttm) 60.08B
Shares Out 9.33M
EPS (ttm) 6,437.95
PE Ratio 20.18
Forward PE n/a
Dividend 2,400.00 (1.90%)
Ex-Dividend Date Apr 21, 2026
Volume 115
Average Volume 880
Open 129,900
Previous Close 126,500
Day's Range 129,900 - 129,900
52-Week Range 100,200 - 189,000
Beta -0.20
RSI 43.71
Earnings Date Apr 24, 2026

About HNX:PMC

Pharmedic Pharmaceutical Medicinal Joint Stock Company manufactures and sells pharmaceutical products in Vietnam. The company offers over the counter drug products, such as medicines from medicinal herbs; minerals and vitamins; eye, ENT, and cough treatment; disinfectants; anti-allergic drugs; gastrointestinal and hepatobiliary drugs; external medications; drugs to treat parasites and bacterial infections analgesic, antipyretic, anti-inflammatory, and gout treatment; cardiovascular and diabetes; and psychoactive drugs. It is also involved in th... [Read more]

Industry Pharmaceutical Preparations
Founded 1981
Employees 516
Stock Exchange Hanoi Stock Exchange
Ticker Symbol PMC
Full Company Profile

Financial Performance

In 2025, HNX:PMC's revenue was 546.57 billion, an increase of 9.71% compared to the previous year's 498.18 billion. Earnings were 60.08 billion, an increase of 2.71%.

Financial Statements

News

There is no news available yet.